Sotera Health Co. (SHC) Reports In-Line Q1 EPS, reaffrims guidance

Sotera Health Co. (NASDAQ: SHC) reported Q1 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $248 million versus the consensus estimate of $244.56 million.

Reaffirming 2024 Outlook

Today, Sotera Health is reaffirming the 2024 outlook first provided on February 27, 2024. As a reminder, the outlook is:

Net revenues and Adjusted EBITDA growth in the range of 4.0% to 6.0%,
Interest Expense in the range of $170 million to $180 million,
Tax rate applicable to Adjusted Net Income(2) in the range of 31.5% to 34.5%,
Adjusted EPS in the range of $0.67 to $0.75, versus the consensus of $0.71
A weighted-average fully diluted share count in the range of 283 million to 285 million shares,
Capital expenditures in the range of $205 million to $225 million.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Accenture downgraded by TD Cowen on AI concerns